Flagship Biosciences reaches milestone with “fit-for-purpose” digital pathology services

Flagship Biosciences’ completes its 400th study with tissue image analysis, and fit-for-purpose IHC and ISH assay development Westminster, CO – April 5, 2015 – Since 2009, Flagship Biosciences has grown to become recognized as the clear industry leader in the delivery of precision pathology reports quantifying a given endpoint in tissue studies. These reports are […]

Read More

Flagship announces relocation and consolidation of offices and laboratory

“Our new location will allow us to continue to grow to meet the demand for our services, and improve logistics in all phases of our operations.” Westminster, CO – Aug, 26, 2014 – Flagship Biosciences LLC, a leading provider of tissue image analysis services to the pharmaceutical and medical device industries, has announced a laboratory […]

Read More

Sarepta Enters into Partnership with Flagship Biosciences in Muscular Dystrophy

New technology designed to speed dystrophin measurement while ensuring consistency Automation of dystrophin measurement will aid development of Sarepta’s Duchenne muscular dystrophy candidates Cambridge, Mass. – Aug 20, 2014 – Sarepta Therapeutics, Inc, a developer of innovative RNA-based therapeutics, and Flagship Biosciences LLC, a leading tissue-based companion diagnostics firm, today announced a multi-year, multi-product partnership […]

Read More

Image Analysis based Companion Diagnostics (CDx) on Leica’s Aperio ePathology platform

Flagship Biosciences’ custom image analysis development leverages Leica Biosystems’ strong installed base in digital pathology Boulder, CO – April 30, 2014 – Flagship Biosciences announces it has reached agreement with Leica Biosystems to allow its custom algorithms to be utilized in companion diagnostics development on the Aperio ePathology platform. The agreement allows Flagship’s quantitative analysis […]

Read More

Flagship appoints new Head of Biology

Boulder, CO – April 3 2014 – Flagship Biosciences announced that Dr. Anthony J. Milici has been appointed Head of Biology. Dr. Milici brings over 30 years of pharmaceutical drug development experience in the areas of neurodegenerative disease, inflammation, and oncology. Prior to joining Flagship, Dr. Milici was head of a neuroscience imaging lab with […]

Read More

Quantitative diagnostic antibody drug conjugate presentation

Flagship Biosciences presents quantitative diagnostic antibody development process at Protein Science Week Palm Springs, CA – Jan. 14, 2014 – Flagship presented an in-depth look at companion diagnostic development at Protein Science Week. The presentation, Immunohistochemistry Based Companion Diagnostic Strategies for Antibody Drug Conjugates, covered Flagship Bioscience’s novel approach to developing assays and biomarkers in […]

Read More

Enzo and Flagship advance in situ hybridization CDx

Enzo Biochem and Flagship Biosciences partner to provide tissue-based companion diagnostics offering complete solution for in situ hybridization development to pharmaceutical companies New York, NY – December 11, 2013 – Enzo Biochem Inc. (NYSE:ENZ) and Flagship Biosciences LLC, of Boulder, CO, today announced a partnership in tissue-based companion diagnostics that will enable personalized diagnosis and treatment […]

Read More

Flagship Biosciences presents immunology image analysis validation research

Validation of an Image Analysis Algorithm to Quantify Leukocyte Populations Using Whole Slide Digital Image Analysis poster presented at SITC National Harbor, MD – Nov. 7, 2013 – Abstract- In recent years, the tumor microenvironment (TME) has been identified as an important factor influencing the growth and metastasis of the tumor. In the TME, different classes […]

Read More

Article published using AngioMap for evaluating microvessel density in multiple myeloma

Flagship and University of Utah publish article on evaluating the plasma cell distribution with the bone marrow vascular niche Boulder, CO – Sept. 16 2013 – In multiple myeloma, bone marrow angiogenesis is typically increased and microvessel density (MVD) is a known indicator of poor prognosis. The technical difficulties associated with consistently measuring three dimensional […]

Read More

Flagship Boulder location undamaged by flood

Boulder, CO – 17 – Sept. – 2013 – A torrential 100 year flood left nearby towns and much of the foothills west of Boulder, Colorado damaged or inaccessible this week, as a massive stormed dumped almost 16″ of rain over a few days. The Flagship team was largely unaffected by the storm and flooding, […]

Read More